Methylprednisolone Terminated Phase 2 Trials for Multiple Myeloma and Plasma Cell Neoplasm / Chronic Myeloproliferative Disorders / Unusual Cancers of Childhood / Myelodysplastic/Myeloproliferative Neoplasms / Myelodysplastic Syndromes (MDS) / Malignant Lymphomas / Leukemias Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00281879Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer
NCT00354172Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers.
NCT01005914Pegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00248534Rituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin's Lymphoma